Why Medline Inc.’s (MDLN) Stock Is Up 10.52%
As of Wednesday, November 04, Medline Inc.’s MDLN share price has surged by 10.52%, which has investors questioning if this is right time to sell.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Tudor Pop
Rosalio Madrigal
Rosalio Madrigal
Tudor Pop
| Share Statistics | MDLN | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $34,417.0 | $380.3 | 91% |
|
| Shares Out (Mil) | 1,316.4 | 41.2 | 95% |
|
| Institutional Ownership | 98.3% | 84.0% | 77% |
|
| Float (Mil) | 382.0 | 35.2 | 82% |
|
| Beta | na | 0.85 | na |
|
| Avg Daily Volume (000s) | 11,270 | 341 | 96% |
|
| Price Change (52-week) |
na | 59.6% | na |
|
| Growth | MDLN | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | na | (5.6%) | na |
|
| EPS (5yr) | na | 10.6% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (16.0%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 23 | 24 | 25 | |
| Current EPS | $0.397 | $1.571 | $1.543 | |
| Month Ago EPS | $0.402 | $1.544 | $1.575 | |
| # Rev Up | 8 | 5 | 3 | |
| # Rev Down | 9 | 1 | 2 | |
| Three Months Ago EPS | $0.403 | $1.556 | $1.582 | |
| Year/Year Chg | 81.3% | 9.8% | 23.1% | |
| Financials | MDLN | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $30,680 | $127 | 94% |
|
| Net Income (TTM) (Mil) | $566 | ($9) | 79% |
|
| EPS (TTM) | $0.652 | ($0.300) | 55% |
|
| Operating Cash Flow (TTM) (Mil) | $2,381 | ($1) | 89% |
|
| Net Cash Flow (TTM) (Mil) | $1,368 | $2 | 96% |
|
| Long-Term Debt (Q1) (Mil) | $12,551 | $25 | 93% |
|
| Enterprise Value (Q1) (Mil) | $51,741 | $400 | 92% |
|
| Valuation | MDLN | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.92 | 2.62 | 68% |
|
| P/E | 60.1 | 26.0 | 89% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.3 | na |
|
| Ratios | MDLN | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 24.4% | 59.1% | 27% |
|
| Net Margin | 1.8% | (4.5%) | 36% |
|
| ROA | 1.5% | (11.0%) | 51% |
|
| ROE | 4.0% | (8.5%) | 41% |
|
| Liabilities to Assets | 51.7% | 45.9% | 45% |
|
| F-Score | 5 | 4 | na |
|
Medline Inc. did not pass any screens on 11/16/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors